Sweat test for babies: comparing arm and leg collection
Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.
This trial checks if taking sweat samples from a baby's arm or leg is equally good for diagnosing cystic fibrosis (CF), a genetic condition that affects the lungs and digestion. It may help make sweat testing easier for babies and their families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must weigh at least 3 kilograms (about 6.6 pounds).
- Your baby must have had a positive newborn screening for cystic fibrosis, be a sibling of a child with CF, or be a healthy newborn from the maternity unit at UZ Brussel.
- Your baby cannot have any chromosomal, metabolic, or heart conditions.
- Your baby cannot have eczema or significant skin problems on the arms or legs.
- Your baby cannot be on systemic corticosteroids (steroid medicine) or be critically ill.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares physical abilities between children with cystic fibrosis and healthy children. It aims to find differences that could lead to better care and therapies.
This study tests a new method to detect bacteria in the lungs of people with cystic fibrosis (CF) by analyzing mucus samples. It aims to improve how we diagnose and treat lung infections.
This study looks at new, advanced tests to help doctors better diagnose cystic fibrosis in people whose current test results are not clear. Participation involves a rectal biopsy, which helps researchers study how the CFTR protein works in the body.
This study follows women with cystic fibrosis (CF) during pregnancy and after birth, and checks on their babies and young children. The goal is to learn more about how CF affects pregnancy and child development.
This trial tests a new device that measures how your sweat glands react to a common asthma medication. It aims to better classify people with cystic fibrosis or related diseases, and also includes healthy volunteers and carriers.
This trial tests a new skin sensor that measures sweat to help diagnose cystic fibrosis. It compares results from people with CF and healthy volunteers to see if the device works accurately.
Hear when a new Cystic Fibrosis (CF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.